Tenaya Therapeutics operates as a publicly traded corporate enterprise listed on the NASDAQ stock exchange under the ticker symbol TNYA. Its common shares are actively bought and sold by institutional and retail investors, requiring the biopharmaceutical firm to adhere strictly to public SEC reporting standards, quarterly financial disclosures, and regulatory governance.